Skip to content

Study of bupivacaine liposomes for pain management during cardiac surgery

Study of bupivacaine liposomes for pain management during cardiac surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075287
Enrollment
Unknown
Registered
2023-08-31
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac surgery

Interventions

Bupivacaine liposome group:Ultrasound-guided liposomal block with bupivacaine
Bupivacaine hydrochloride injection group:Block with bupivacaine hydrochloride injection under ultrasound guidance

Sponsors

Xiangya Hospital,Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) The patient who intends to undergo median open-heart valve surgery; (2) Age 18-65 years old; (3) Voluntarily participate in and sign the informed consent;

Exclusion criteria

Exclusion criteria: (1) Allergic to the ingredients in the treatment solution; (2) The estimated postoperative tracheal intubation time was > 24h; (3) Combined with severe brain, liver and kidney dysfunction, endocrine system diseases and serious infectious diseases; (4) History of sternotomy; (5) long-term use of opioids (6) pregnant or lactating women;

Design outcomes

Primary

MeasureTime frame
The accumulation of morphine milligram equivalent 72 hours after surgery;

Secondary

MeasureTime frame
Number of analgesic pump compressions;Pain scores after surgery;Extubation time;Postoperative cardiovascular adverse reactions;Incidence of nausea and vomiting;Sleep and activity after surgery;Digestive tract function recovery time;Postoperative relief of analgesia;Postoperative complications in hospital;Postoperative respiratory function;Length of stay and hospitalization in ICU;Adverse reactions to analgesics;Long-term chronic pain, analgesic drug use and recovery;

Countries

China

Contacts

Public ContactWang E

Xiangya Hospital, Central South University

981574629@qq.com+86 188 7488 9950

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026